Here’s a ranking of the five best-performing stocks in March – as well as an overview of the news driving each company’s buying frenzy… No. 5: Moxian Inc. (MOXC) Shares of Moxian, a Chinese social networking platform, rocketed 73.3% from $0.45 on Feb. 28 to $0.78 as of the March 7 close. The stock experienced […]
Read MoreIt might be the year of the pig but with Chinese stocks, 2019 looks like the year of the bull. These are the top 3 Chinese stocks to buy right now.
Read MoreOne of the things about stocks in the Consumer Discretionary sector that is interesting is how widely disparate they are. The general perception of most stocks in the sector is that they are highly cyclical, sensitive to inflationary pressures that make them more risky when the economy is in trouble. One industry in the sector […]
Read MoreThis stock just kicked Canopy Growth out of Cowen’s top marijuana stock pick seat, and the firm now rates it an Outperform. Here’s why.
Read MoreThese 2 biotechs could see massive gains this year. Here’s why.
Read MoreThis secret portfolio is trouncing the market – here are 6 of the stocks included in it.
Read MoreThe market has been nervous this week – whether you want to cite trade war fatigue, global economic fears that could be rippling into U.S. economic metrics, or earnings reports from some of the market’s biggest companies that have disappointed investors. I think it’s true that tariffs between the U.S. and its biggest trading partners […]
Read MoreThe investment seeks the daily changes in percentage terms of its shares’ per share net asset value (“NAV”) to reflect the daily changes in percentage terms of the spot price of light, sweet crude oil delivered to Cushing, Oklahoma, as measured by the daily changes in the price of a specified short-term futures contract on […]
Read MoreVitamin Shoppe, Inc., through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded […]
Read MoreOil prices have been on a tear this year following a particularly awful performance last quarter. The price of West Texas Intermediate (WTI) – the most widely used pricing benchmark in the U.S. – tumbled more than 38% during the October-December period. WTI has since rebounded nearly 24% this year to $56.14 as of March […]
Read MoreOne of the classic benchmark of the economy’s health and strength is the housing market. Stocks of retail companies like Home Depot (HD) and Lowe’s (LOW) often serve as proxies of to guide the market’s perception of the housing market, but it also isn’t uncommon to see experts and analysts referring to homebuilders like D.R. […]
Read MoreClean Energy Fuels Corp. provides natural gas as an alternative fuel for vehicle fleets in the United States and Canada. The company supplies renewable natural gas (RNG), compressed natural gas (CNG), and liquefied natural gas (LNG) for light, medium, and heavy-duty vehicles; and provides operation and maintenance services for vehicle fleet customer stations. It also […]
Read MoreShares of Kohl’s Corp. (KSS) surged to fresh highs on Tuesday thanks to a stronger-than-expected fourth-quarter earnings report. The department store chain surprised on just about every level, which galvanized investors formerly discouraged by the stock’s rocky performance over the last year. While it’s easy to forecast the company’s demise as Amazon.com Inc. (AMZN) expands […]
Read MoreMarket news for the last while has seemed to be almost completely focused on the trade war between the U.S. and China – to the point that investors seem to be getting what some might call “trade fatigue” – which could be a point where even if or when a deal is made, the broad […]
Read MoreGalmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. The company is develops Aramchol, an oral therapy, which is in ARREST study, a Phase IIb clinical study for the treatment of patients with overweight or obesity, and who are pre-diabetic or type-II-diabetic with non-alcoholic steato-hepatitis. […]
Read More